Statistics

Total Visits

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group14

Select a period of time:

Number of views in the range

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group8

Views

Views
May 20243
June 20242
July 20241
August 20240
September 20241
October 20241
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
 

Top cities views

Views
Fort Worth1